Visualisation specialist Barco has launched the Mammo Tomosynthesis 5MP, the first display system that has been cleared by the US Food and Drug Administration (FDA) for breast tomosynthesis. The display comes with some groundbreaking technologies specifically developed for multi-modality mammography. Barco, a global technology company, designs and develops visualization products for a variety of selected professional markets. It has its own facilities for Sales & Marketing, Customer Support, R&D and Manufacturing in Europe, North America and Asia Pacific. The Mammo Tomosynthesis 5MP efficiently displays high-quality multi-modality images. Barco’s proprietary RapidFrame

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.